Best Options Strategy for AZN
Looking for the best options strategy for AstraZeneca (AZN)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live AZN option chain right now, and a simple map from your view on AZN to the strategy that fits it. Model any of them in the calculator before you trade.
About AZN
AstraZeneca (AZN) is a major company in pharmaceuticals (oncology and biopharma). Options traders on AZN tend to watch oncology pipeline, trial readouts and earnings, since these can drive large moves in the share price.
AZN for options traders
AstraZeneca trades with a notably subdued implied volatility profile compared to most pharma names — its IV tends to sit in the lower range of the sector, reflecting the stability of a diversified, large-cap biopharma with multiple revenue streams rather than dependence on a single drug. The biggest single-day moves tend to cluster around quarterly earnings, key oncology trial readouts, and FDA or EMA regulatory decisions on major pipeline candidates. Because AZN is dual-listed and carries meaningful international exposure, currency dynamics and macro risk-off episodes can also nudge IV higher at the margins.
The relatively low baseline IV makes AZN a natural fit for income-oriented strategies: covered calls are a staple for shareholders looking to enhance yield, and cash-secured puts appeal to traders who want to build a position at a discount. Options liquidity is adequate for near-the-money strikes in front-month and next-month expirations, but the market thins out quickly for far out-of-the-money strikes or longer-dated contracts. Traders who want to play a binary catalyst — a major trial result or regulatory ruling — often use long straddles or risk reversals, accepting that the compressed starting IV means the breakeven move required is lower than it would be on a more volatile biotech name.
Today's top-scoring strategy for AZN
Our engine ranks defined-risk strategies on the live AZN chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $140 | $0.55 |
| Sell | 1× | PUT | $160 | $4.65 |
| Sell | 1× | CALL | $160 | $7.35 |
| Buy | 1× | CALL | $180 | $1.13 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $202 | −$949 | −$922 | −$884 | −$843 | −$804 |
| $194 | −$893 | −$839 | −$784 | −$736 | −$697 |
| $186 | −$737 | −$668 | −$614 | −$578 | −$556 |
| $178 | −$429 | −$395 | −$383 | −$386 | −$400 |
| $170 | −$30 | −$89 | −$151 | −$210 | −$265 |
| $162 | $223 | $88 | −$26 | −$121 | −$202 |
| $153 | $98 | −$4 | −$96 | −$176 | −$246 |
| $145 | −$331 | −$329 | −$343 | −$366 | −$394 |
| $137 | −$736 | −$679 | −$637 | −$609 | −$594 |
| $129 | −$923 | −$886 | −$846 | −$808 | −$775 |
| $121 | −$964 | −$955 | −$939 | −$917 | −$893 |
Live scan from 2026-08-10 · quotes delayed ~15 minutes
Historical backtest: how a Iron Butterfly on AZN would have performed
We approximated a Iron Butterfly on AZN, entered repeatedly over the past year (91 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real AZN price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
AZN is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 28% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on AZN currently price in about 28% implied volatility, versus roughly 42% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
AZN's IV Rank is 16/100: implied volatility sits 16% of the way between its 30-day low (27%) and high (35%), and is above 23% of recorded days. Premium is historically cheap, which favours net-debit strategies like long options and debit spreads.
Off that volatility, the options market is pricing a move of about ±$14.87 (±9%) in AZN by 2026-09-18 — a range of roughly $147 to $176. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on AZN carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
AZN options chain highlights: open interest, volume and skew
The live AZN options chain shows a put/call open-interest ratio of 1.36 (bearish-leaning (more puts)), with at-the-money implied volatility near 28.6%. Open interest clusters at the $165 call — a common resistance "wall" — and the $82.5 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
AZN insider trading activity (SEC Form 4)
Open-market insider transactions at AZN over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Sharma Mani | Sell | 11,893 | $2.2M | 2026-05-20 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Liquidity and tradeability
AZN options are reasonably liquid, with bid-ask spreads around 4.3% near the money. Defined-risk spreads and condors are workable; use limit orders and watch the fill on wider multi-leg trades.
Earnings & IV crush
AZN's next earnings report is due around October 30, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
AZN pays a dividend of about 2% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $250.5B
- Beta (vs market)
- 0.21
- 52-week range
- $145.80–$212.71 (23% up the range)
- Short interest
- 0.2% of float · 1.0 days to cover
Other strong setups for AZN
If your view on AZN differs, these also scored well in the latest scan:
How to choose an options strategy for AZN
Start with your outlook on AZN, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while AZN stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open AZN in the free calculator →
Frequently asked questions
What is the best options strategy for AZN?
It depends on your outlook. Bullish traders often use a long call or bull call spread on AZN; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are AZN options liquid enough to trade?
AstraZeneca (AZN) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade AZN options?
Buying a single AZN call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade AZN or any security. Do your own research.
What does AstraZeneca do?
AstraZeneca (AZN) operates in the Drug Manufacturers - General industry. The "About AstraZeneca" section above gives a fuller picture of what the company does and how it earns money.
Does AstraZeneca pay a dividend?
Yes — AstraZeneca currently pays a dividend yielding about 2%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does AstraZeneca next report earnings?
AstraZeneca's next earnings are expected around October 30, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to AZN
Comparing AZN with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
- Industry
- Drug Manufacturers - General
- Employees
- 96,100
- CEO
- Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
- Phone
- 44 20 3749 5000
- Website
- www.astrazeneca.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.